Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitors
2018
• Diarylpyrimidine (DAPY) NNRTIs used in treatment and prevention therapy are greatly affected by resistance-associated mutations.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
3
Citations
NaN
KQI